Your browser doesn't support javascript.
loading
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
Jørgensen, Kristin K; Goll, Guro L; Sexton, Joe; Bolstad, Nils; Olsen, Inge C; Asak, Øivind; Berset, Ingrid P; Blomgren, Ingrid M; Dvergsnes, Katrine; Florholmen, Jon; Frigstad, Svein O; Henriksen, Magne; Hagfors, Jon; Huppertz-Hauss, Gert; Haavardsholm, Espen A; Klaasen, Rolf A; Moum, Bjørn; Noraberg, Geir; Prestegård, Ulf; Rydning, Jan H; Sagatun, Liv; Seeberg, Kathrine A; Torp, Roald; Vold, Cecilia; Warren, David J; Ystrøm, Carl M; Lundin, Knut E A; Kvien, Tore; Jahnsen, Jørgen.
Afiliação
  • Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Sykehusveien 75, 1478, Lørenskog, Norway. kristin.kaasen.jorgensen@ahus.no.
  • Goll GL; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Sexton J; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Olsen IC; Research Support Services CTU, Oslo University Hospital, Oslo, Norway.
  • Asak Ø; Department of Gastroenterology, Gjøvik Hospital, Gjøvik, Norway.
  • Berset IP; Department of Gastroenterology, Ålesund Hospital, Ålesund, Norway.
  • Blomgren IM; Department of Gastroenterology, Haugesund Hospital, Haugesund, Norway.
  • Dvergsnes K; Department of Gastroenterology, Sørlandet Hospital, Kristiansand, Norway.
  • Florholmen J; Department of Gastroenterology, University Hospital North Norway, Tromsø, Norway.
  • Frigstad SO; Research Group Gastroenterology and Nutrition, Norwegian Arctic University, Tromsø, Norway.
  • Henriksen M; Department of Medicine, Vestre Viken Bærum Hospital, Gjettum, Norway.
  • Hagfors J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Huppertz-Hauss G; Department of Gastroenterology, Østfold Hospital, Fredrikstad, Norway.
  • Haavardsholm EA; Patient Representative, Landsforeningen for Fordøyelsessykdommer, Oslo, Norway.
  • Klaasen RA; Department of Gastroenterology, Telemark Hospital, Skien, Norway.
  • Moum B; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Noraberg G; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Prestegård U; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Rydning JH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Sagatun L; Department of Gastroenterology, Oslo University Hospital Ullevål, Oslo, Norway.
  • Seeberg KA; Department of Gastroenterology, Sørlandet Hospital, Arendal, Norway.
  • Torp R; Department of Gastroenterology, Lillehammer Hospital, Lillehammer, Norway.
  • Vold C; Department of Gastroenterology, Akershus University Hospital, Sykehusveien 75, 1478, Lørenskog, Norway.
  • Warren DJ; Department of Gastroenterology, Diakonhjemmet Hospital, Oslo, Norway.
  • Ystrøm CM; Department of Gastroenterology, Sankt Olav's Hospital, Trondheim, Norway.
  • Lundin KEA; Department of Gastroenterology, Vestfold Hospital, Tønsberg, Norway.
  • Kvien T; Department of Gastroenterology, Hamar Hospital, Hamar, Norway.
  • Jahnsen J; Department of Gastroenterology, Bodø Hospital, Bodø, Norway.
BioDrugs ; 34(5): 681-694, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32965617
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article